Serina Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $13.2M | $-11.8M | $584.0K |
| FY2022 | $18.1M | $-17.2M | $645.0K |
| FY2023 | — | $-32.3M | $7.6M |
| FY2024 | — | $641.0K | $3.7M |
| FY2025 | — | $-37.0K | $3.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $13.2M | $-11.8M | $584.0K |
| FY2022 | $18.1M | $-17.2M | $645.0K |
| FY2023 | — | $-32.3M | $7.6M |
| FY2024 | — | $641.0K | $3.7M |
| FY2025 | — | $-37.0K | $3.1M |